查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1544015

全球转染试剂与设备市场

Transfection Reagents and Equipment
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年全球转染试剂和设备市场将达18亿美元

2023年全球转染试剂和设备市场估计为12亿美元，预计到2030年将达到18亿美元，2023-2030年分析期间复合年增长率为6.1%。转染试剂是本报告分析的细分市场之一，预计复合年增长率为 6.6%，到分析期结束时将达到 12 亿美元。分析期间，转染设备领域的复合年增长率预计为 5.3%。

美国市场预估为3.241亿美元，中国预期复合年增长率为5.7%

预计2023年美国转染试剂和设备市场规模将达3.241亿美元。中国作为全球第二大经济体，预计2030年市场规模将达2.827亿美元，2023-2030年复合年增长率为5.7%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 5.3% 和 5.2%。在欧洲，德国的复合年增长率预计为 4.7%。

全球转染试剂和设备市场 - 主要趋势和驱动因素总结

什么是转染试剂和设备以及为什么需要它们？

转染试剂和设备是分子生物学和遗传学研究中用于将核酸（DNA 或 RNA）引入细胞的重要工具。这些工具对于各种应用至关重要，包括基因表现研究、蛋白质生产和基因改造生物的开发。转染试剂，例如脂质、聚合物和电穿孔溶液，透过促进核酸的摄取和表现来促进核酸进入细胞。电穿孔器和显微注射器等转染设备提供了实现高效可靠转染所需的技术。这些工具对于提高我们对基因功能、疾病机制和新疗法开发的理解至关重要。

转染试剂和设备如何促进基因研究？

转染试剂和设备透过提供可靠且有效的方法将遗传物质引入细胞来促进遗传研究。这些工具使研究人员能够研究基因功能和调控、建立疾病模型并开发基于基因的治疗方法。先进的转染试剂已被开发用于提高转染效率、降低细胞毒性并能够递送大或复杂的核酸。例如，电穿孔装置利用电脉衝在细胞膜上产生临时孔，使核酸能够有效率地进入细胞。透过优化转染过程，这些试剂和仪器促进了准确且可重复的实验，加速了科学发现和创新疗法的开发。

为什么转染试剂和设备的需求不断增加？

由于几个重要因素，对转染试剂和设备的需求增加。随着基因功能的阐明和基因疗法的发展，遗传和基因组研究的增加推动了对先进转染工具的需求。生物技术的进步，包括 CRISPR-Cas9 和其他基因编辑技术，需要有效的转染方法才能成功。对个人化医疗和标靶治疗的日益关注也推动了对可靠转染系统的需求，以开发和测试新治疗方法。此外，生物技术和製药行业的成长以及研发资金的增加正在支持转染试剂和设备市场的扩张。学术和工业研究对高效且高度可重复的转染方法的需求也推动了转染方法的广泛使用。

推动转染试剂和设备市场成长的因素有哪些？

转染试剂和设备市场的成长受到多种因素的推动。人们对基因研究和基因治疗开发的日益关注需要先进的转染工具来促进这些研究。转染试剂和装置的技术进步，例如改进的递送方法和降低的细胞毒性，提高了它们的效率和可靠性，并促进了它们的采用。生物技术和製药领域的扩张以及研究经费的增加正在支持市场的成长。个人化医疗的兴起和对标靶治疗的需求也推动了对高效转染系统的需求。此外，CRISPR-Cas9等基因编辑技术的广泛应用需要可靠的转染方法，进一步推动市场成长。对开发遗传性疾病和癌症新治疗方法的重视强调了转染试剂和设备在推进医学研究和治疗开发中的重要性。

受访企业范例（42家知名企业）

  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Life Technologies Corporation
  • Lonza Group AG
  • MilliporeSigma
  • PolyPlus Battery Company（PPBC）
  • Promega Corporation
  • Qiagen NV
  • SignaGen Laboratories
  • Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP15289

Global Transfection Reagents and Equipment Market to Reach US$1.8 Billion by 2030

The global market for Transfection Reagents and Equipment estimated at US$1.2 Billion in the year 2023, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Transfection Reagents, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Transfection Equipment segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$324.1 Million While China is Forecast to Grow at 5.7% CAGR

The Transfection Reagents and Equipment market in the U.S. is estimated at US$324.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$282.7 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.3% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Transfection Reagents and Equipment Market - Key Trends & Drivers Summarized

What are Transfection Reagents and Equipment and Why are They Essential?

Transfection Reagents and Equipment are crucial tools used in molecular biology and genetic research to introduce nucleic acids (DNA or RNA) into cells. These tools are essential for various applications, including gene expression studies, protein production, and the development of genetically modified organisms. Transfection reagents, such as lipids, polymers, and electroporation solutions, facilitate the delivery of nucleic acids into cells by promoting their uptake and expression. Transfection equipment, including electroporators and microinjectors, provides the necessary technology to achieve efficient and reliable transfection. These tools are fundamental for advancing our understanding of gene function, disease mechanisms, and the development of novel therapeutics.

How Do Transfection Reagents and Equipment Enhance Genetic Research?

Transfection Reagents and Equipment enhance genetic research by providing reliable and efficient methods for introducing genetic material into cells. These tools enable researchers to study gene function and regulation, model diseases, and develop gene-based therapies. Advanced transfection reagents have been developed to improve transfection efficiency, reduce cytotoxicity, and enable the delivery of large or complex nucleic acids. Electroporation equipment, for instance, uses electrical pulses to create temporary pores in cell membranes, allowing nucleic acids to enter cells with high efficiency. By optimizing the transfection process, these reagents and equipment facilitate accurate and reproducible experiments, accelerating scientific discoveries and the development of innovative treatments.

Why is the Demand for Transfection Reagents and Equipment Increasing?

The demand for Transfection Reagents and Equipment is increasing due to several critical factors. The rise in genetic and genomic research, driven by the growing understanding of gene functions and the development of gene therapies, fuels the need for advanced transfection tools. Advances in biotechnology, including CRISPR-Cas9 and other gene-editing technologies, require efficient transfection methods for successful implementation. The increasing focus on personalized medicine and targeted therapies also drives the demand for reliable transfection systems to develop and test new treatments. Additionally, the growth of the biotechnology and pharmaceutical industries, along with increased funding for research and development, supports the expanding market for transfection reagents and equipment. The need for efficient and reproducible transfection methods in academic and industrial research further contributes to their widespread adoption.

What Factors are Driving the Growth of the Transfection Reagents and Equipment Market?

The growth in the Transfection Reagents and Equipment market is driven by several factors. The increasing focus on genetic research and the development of gene therapies necessitate advanced transfection tools to facilitate these studies. Technological advancements in transfection reagents and equipment, such as improved delivery methods and reduced cytotoxicity, enhance their efficiency and reliability, driving their adoption. The expansion of the biotechnology and pharmaceutical sectors, coupled with increased research funding, supports market growth. The rise of personalized medicine and the need for targeted therapies also propel the demand for efficient transfection systems. Additionally, the growing application of gene editing technologies like CRISPR-Cas9 requires reliable transfection methods, further boosting market growth. The emphasis on developing novel treatments for genetic disorders and cancers underscores the importance of transfection reagents and equipment in advancing medical research and therapeutic development.

Select Competitors (Total 42 Featured) -

  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Life Technologies Corporation
  • Lonza Group AG
  • MilliporeSigma
  • PolyPlus Battery Company (PPBC)
  • Promega Corporation
  • Qiagen NV
  • SignaGen Laboratories
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Transfection Reagents and Equipment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Gene Therapy and Genetic Research
    • Technological Innovations in Transfection Methods
    • Expansion of Biotechnology and Pharmaceutical Industries
    • Increasing Investment in Cancer Research and Immunotherapy
    • Regulatory Approvals and Advancements in Clinical Applications
    • Growing Adoption of High-Throughput Screening
    • Market Demand for Efficient and Reliable Reagents
    • Impact of Personalized Medicine on Transfection Techniques
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Gene Expression Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Gene Expression Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Gene Expression Studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Protein Production by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Protein Production by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Protein Production by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Transgenic Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Transgenic Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Transgenic Models by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Therapeutic Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Therapeutic Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Therapeutic Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Transfection Reagents and Equipment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Transfection Reagents and Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Transfection Reagents and Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Electroporation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Electroporation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Electroporation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Liposomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Liposomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Liposomes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Particle Bombardment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Particle Bombardment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Particle Bombardment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Microinjection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Microinjection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Microinjection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Adenoviral Vectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Adenoviral Vectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Adenoviral Vectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Calcium Phosphate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Calcium Phosphate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Calcium Phosphate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: World 16-Year Perspective for Other Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: USA 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • JAPAN
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • CHINA
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: China 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: China 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • EUROPE
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Transfection Reagents and Equipment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Transfection Reagents and Equipment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • FRANCE
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: France 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: France 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • GERMANY
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Italy 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 122: UK Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: UK 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: UK 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Rest of World 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 155: Rest of World Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of World Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of World 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030

IV. COMPETITION